Entry Inhibitors Directed Towards Glycoprotein gp120: An Overview on a Promising Target for HIV-1 Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|6|751-771

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.6, 2013-01, pp. : 751-771

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR and Molecular Docking Studies of HIV-1 Entry Inhibitors Targeting GP120-CD4 Binding Site

By  

Anti-Infective Agents, Vol. 15, Iss. 2, 2018-01 ,pp. : 115-130

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 10, 2016-04 ,pp. : 1074-1090

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 gp120: A Target for Therapeutics and Vaccine Design

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 122-135

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 gp41 as a Target for Viral Entry Inhibition

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1805-1825

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of HIV-1 Entry

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1784-1799

Bentham Science Publishers

Access to resources Recommend Favorite